The theme of this lecture was how genome information gives impact on R&D of pharmaceuticals. The speaker first describes what R&D of pharmaceuticals have been done, then does current status of genome analysis, human genes and genes which bring diseases on human beings, and principle of nowadays' R&D of pharmaceuticals, that is, relation among ligands, receptors, and antagonists. Ones likely find targets for R&D of new pharmaceuticals if they refer to gene study results. Once ones find those targets, they combine them with such traditional subjects areas as chemistry, physical chemistry, pharmacology and biology in their further R&D to lead to new pharmaceuticals. The speaker emphasizes significance in progress of bioinformatics where vast amount of information or knowledge being generated through gene studies can be linked effectively.
View full abstract